Precision medicine is an emerging paradigm in clinical pharmacology that aims to optimize therapeutic outcomes by tailoring medical treatment to individual patient characteristics, including genetic, environmental, and lifestyle factors. Unlike the conventional “one-size-fits-all” approach, precision medicine enables more accurate drug selection, dosing, and monitoring, thereby improving efficacy and minimizing adverse drug reactions. Advances in genomic technologies, bioinformatics, and biomarker discovery have significantly enhanced the understanding of interindividual variability in drug response. Pharmacogenomics plays a pivotal role in this approach by identifying genetic polymorphisms that influence drug metabolism, transport, and receptor activity. The application of precision medicine has shown significant benefits across various therapeutic areas, including oncology, cardiovascular diseases, neurological disorders, and infectious diseases. Targeted therapies, such as Trastuzumab in HER2-positive breast cancer, exemplify the clinical utility of this approach. Furthermore, the integration of advanced technologies such as next-generation sequencing, artificial intelligence, and big data analytics is accelerating its adoption in routine clinical practice. Despite its promising potential, challenges such as high costs, limited accessibility, ethical concerns, and the need for standardized clinical guidelines hinder widespread implementation. Nevertheless, ongoing research and technological advancements are expected to overcome these barriers. In conclusion, precision medicine represents a transformative advancement in clinical pharmacology, offering a more personalized, safe, and effective approach to drug therapy, and holds great promise for improving future healthcare outcomes.
Raj et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: